Interpore Cross introduces shareholder rights plan:
This article was originally published in Clinica
Interpore Cross International has declared a dividend distribution of one preferred share purchase right for each outstanding share of common stock, which will be exercisable if a person or group acquires or offers to acquire more than 15% of the company's common stock. The previous shareholder rights plan terminated when Interpore International merged with Cross Medical Products in May (Clinica No 797, p11). Irvine, California-based Interpore Cross has also approved a repurchase programme for up to $4 million of its common stock, which will run until June 1999.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.